APA (7th ed.) Citation

Lazaar, A. L., Miller, B. E., Donald, A. C., Keeley, T., Ambery, C., Russell, J., . . . Pek, B. (2020). CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: A phase 2b trial. Respiratory Research, 21(1), 1. https://doi.org/10.1186/s12931-020-01401-4

Chicago Style (17th ed.) Citation

Lazaar, Aili L., et al. "CXCR2 Antagonist for Patients with Chronic Obstructive Pulmonary Disease with Chronic Mucus Hypersecretion: A Phase 2b Trial." Respiratory Research 21, no. 1 (2020): 1. https://doi.org/10.1186/s12931-020-01401-4.

MLA (9th ed.) Citation

Lazaar, Aili L., et al. "CXCR2 Antagonist for Patients with Chronic Obstructive Pulmonary Disease with Chronic Mucus Hypersecretion: A Phase 2b Trial." Respiratory Research, vol. 21, no. 1, 2020, p. 1, https://doi.org/10.1186/s12931-020-01401-4.